Latest
Tequin
& Related Newswire
5/19/2006 12:37:00 PM | Antibiotic linked to liver failure 
=(0) The FDA is concerned about the side effect of liver failure in patients taking the antibiotic Ketek. The risk, although small, is three to four times higher than that of similar antibiotics, Avelox, Tequin, and Levaquin. Tequin was withdrawn from the market because of blood sugar complications. The FDA wants increased warnings on the labe...
Read More
5/8/2006 10:26:00 PM | Tequin drugmaker named in class-action lawsuit =(0) A class-action lawsuit has been launched in Canada against Bristol-Myers Squibb over the antibiotic drug Tequin (gatifloxacin). The drug was commonly used to treat conditions such as pneumonia, bronchitis, and skin and urinary tract infections. Problems became known three years ago when some patients developed serious side effects which requir...
Read More
5/3/2006 12:46:00 AM | Antibiotic gatifloxacin (Tequin) pulled from market =(0) The antibiotic Tequin, made by Bristol-Myers Squibb, has been taken off the market due to reports of severe side effects including dangerous fluctuations in blood sugar even among non-diabetics. Other drugs in the same class (fluoroquinolones) have had problems with liver and kidney side effects. Alternatives are available to treat condit...
Read More
5/1/2006 2:14:00 PM | Public Citizen Asks FDA To Ban Antibiotic Tequin =(0) Public Citizen, a well-known consumer activism group, has requested that the FDA incorporate a total ban on the antibiotic Tequin. Tequin has been linked to strange glycemic and blood sugar disorders, including Diabetes. The biggest issue here is a voluntary recall versus a mandated ban. An FDA ban would be a public admonishment against th...
Read More